The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 15, 2020
Filed:
Jun. 18, 2018
Applicants:
Santen Pharmaceutical Co., Ltd., Osaka, JP;
Agc Inc., Tokyo, JP;
Inventors:
Timo Reunamaki, Tampere, FI;
Pertti Pellinen, Lempaala, FI;
Olli Oksala, Tampere, FI;
Kari Lehmussaari, Tampere, FI;
Assignees:
SANTEN PHARMACEUTICAL CO., LTD., Osaka, JP;
AGC INC., Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 31/5575 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01); A61P 27/06 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0048 (2013.01); A61K 9/08 (2013.01); A61K 31/5575 (2013.01); A61K 47/10 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01); A61P 27/06 (2018.01); A61K 47/02 (2013.01); Y02A 50/30 (2018.01); Y10S 514/913 (2013.01);
Abstract
The present invention relates to an ophthalmic aqueous composition containing PGF2α analogues for treating ocular hypertension and glaucoma, to a method for treating ocular hypertension and glaucoma by administering said composition to a subject in need of such treatment, and to a method for increasing aqueous solubility and stability of PGF2α analogues in an aqueous composition.